CEO of Alnylam
Discussing the promising new heart drug results and their potential impact on the space
Best podcasts with CEO of Alnylam
Ranked by the Snipd community
Jun 24, 2024 • 44min
Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24
The CEO of Alnylam discusses the positive results of a new heart drug, potentially impacting the biopharma space. Market trends analyze Nvidia's stock drop and its impact on related companies. Bank opportunities, yen interventions, and challenges faced by companies are also explored.
